Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Jamba (Potchefstroom, South Africa)
|
March 10, 2025
Towards more connection in drought and flood management in the transboundary Limpopo basin
Anne F Van Loon, Alessia Matanó, Sithabile Tirivarombo, et al.
Antiviral Research
|
April 14, 2018
BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo
Mary A Morse, Karla K Balogh, Sarah A Brendle, et al.
Health Technology Assessment (Winchester, England)
|
April 21, 2016
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
Thomas R E Barnes, Verity C Leeson, Carol Paton, et al.
Medecine Sciences : M/S
|
May 23, 2019
[Prevention of liver fibrosis and liver cancer linked to hepatitis B virus in Africa: the Prolifica study]
Damien Cohen, Yusuke Shimakawa, Gibril Ndow, et al.
Journal of Clinical and Experimental Hepatology
|
April 27, 2019
Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for Cholangiocarcinoma
Christopher A Wadsworth, Peter H Dixon, Simon Taylor-Robinson, et al.
Journal of Medicinal Chemistry
|
July 12, 2021
Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit
Francesco Rianjongdee, Stephen J Atkinson, Chun-Wa Chung, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2008
Aryl aminopyrazole benzamides as oral non-steroidal selective glucocorticoid receptor agonists
Heather A Barnett, Diane M Coe, Tony W J Cooper, et al.
Journal of Medicinal Chemistry
|
July 14, 2021
Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors
Simon C C Lucas, Stephen J Atkinson, Chun-Wa Chung, et al.
Journal of Medicinal Chemistry
|
November 29, 2014
Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic, and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles
John Skidmore, Jag Heer, Christopher N Johnson, et al.
Communications Chemistry
|
January 25, 2023
Chemical shielding of H<sub>2</sub>O and HF encapsulated inside a C<sub>60</sub> cage
Samuel P Jarvis, Hongqian Sang, Filipe Junqueira, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Jamba (Potchefstroom, South Africa)
|
March 10, 2025
Towards more connection in drought and flood management in the transboundary Limpopo basin
Anne F Van Loon, Alessia Matanó, Sithabile Tirivarombo, et al.
Antiviral Research
|
April 14, 2018
BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo
Mary A Morse, Karla K Balogh, Sarah A Brendle, et al.
Health Technology Assessment (Winchester, England)
|
April 21, 2016
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
Thomas R E Barnes, Verity C Leeson, Carol Paton, et al.
Medecine Sciences : M/S
|
May 23, 2019
[Prevention of liver fibrosis and liver cancer linked to hepatitis B virus in Africa: the Prolifica study]
Damien Cohen, Yusuke Shimakawa, Gibril Ndow, et al.
Journal of Clinical and Experimental Hepatology
|
April 27, 2019
Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for Cholangiocarcinoma
Christopher A Wadsworth, Peter H Dixon, Simon Taylor-Robinson, et al.
Journal of Medicinal Chemistry
|
July 12, 2021
Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit
Francesco Rianjongdee, Stephen J Atkinson, Chun-Wa Chung, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2008
Aryl aminopyrazole benzamides as oral non-steroidal selective glucocorticoid receptor agonists
Heather A Barnett, Diane M Coe, Tony W J Cooper, et al.
Journal of Medicinal Chemistry
|
July 14, 2021
Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors
Simon C C Lucas, Stephen J Atkinson, Chun-Wa Chung, et al.
Journal of Medicinal Chemistry
|
November 29, 2014
Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic, and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles
John Skidmore, Jag Heer, Christopher N Johnson, et al.
Communications Chemistry
|
January 25, 2023
Chemical shielding of H<sub>2</sub>O and HF encapsulated inside a C<sub>60</sub> cage
Samuel P Jarvis, Hongqian Sang, Filipe Junqueira, et al.
Page
of 9